The VapoFil Journal: Five Long Reads On Labels, Doses And Time

The five articles

Where to start, depending on what you want to know

• If something has changed suddenly, start with the last article. Everything else on this website assumes that step is behind you.
• If you are comparing two bottles and the numbers will not line up, start with the piece on extract ratios. It is the commonest reason they do not.
• If you want to read any panel better, read the one on percentages next. Two conversions, five seconds each, and most labels become legible.
• If you are wondering why an ingredient with an obvious mechanism has no trial behind it, the horny goat weed piece answers that, including why nobody has run one.
• If you have already ordered and want to know what a fair test looks like, start with the article on time.

How these five were chosen

Not from a template. Each one answers a question this particular panel raises, which is why three of the five are about arithmetic: this label prints every amount and declares both extract ratios, so its numbers can be interrogated in a way most of this aisle's cannot.

The fourth is here because timing is the thing buyers get wrong most often and the thing sellers have the least interest in correcting. The fifth is here because a website that sells a supplement for this use case has an obligation to say, once and clearly, when a supplement is the wrong answer.

What none of the five is, is an argument for a purchase. Three of them make the product look worse than the sales page does. One of them, read properly, is an argument for going to an appointment instead of ordering anything at all. That is the point of writing them: a reader who has been told where the weak rows are has some reason to believe the description of the strong ones.

What these five have in common

A method, and it is the same one that governs every other page on this website. Every figure quoted comes from one of three places and says which: the label artwork on the bottle, the seller's own page as read on a stated date, or a published paper carrying a PubMed identifier that is printed so it can be opened.

Where a claim has no evidence behind it, that is written down as a finding rather than filled in with mechanism papers dressed up as trials. Two of the seven rows on this panel have no randomised human trial anywhere, and the second article in this list is entirely about what follows from that. Nothing on this website says the rows are useless; it says nobody has measured them, which is a different statement and the only one the evidence supports.

And where the amount on the label and the amount in the research diverge, both numbers are printed side by side. Five of the seven rows here sit at 20 mg against trial doses ten to thirty times larger. That comparison appears on the home page rather than being buried, and three of these five articles exist to explain how to do it yourself on any bottle in the aisle.

Reading these alongside the product pages

The product pages on this website argue for a specific bottle and say plainly that this desk earns on the order. These five do not argue for anything, and neither do the two guides, which are written for the category rather than for one label.

A reasonable order for somebody who has arrived here cold: read the article on time first, because it sets expectations that everything else depends on. Then the panel page, which transcribes all seven rows with the trial amount beside each one. Then whichever of the three arithmetic pieces matches the number that puzzled you. The last article is the one to read first if anything has changed suddenly, and it is the only one on this website that would rather you did not buy anything today.

Topics deliberately left alone

Three subjects come up constantly in this category and none of them is written about here, for reasons worth stating rather than leaving as gaps.

• Comparisons against named competitors. A page comparing this bottle favourably against three rivals is an advertisement with a table in it, and the version written by the rival reaches the opposite conclusion using the same method. What is here instead is a set of eight questions that works on any bottle, applied at the end to this one with the failures printed.
• Testimonials treated as evidence. The distributor's own review figures are reproduced on the reviews page and described there as layout copy, which is what they are. Building an article around eight summary notes would dress up a distributor's roundup as research.
• Anything resembling a dosage protocol. The label says two capsules a day and that is the whole of what anybody here knows. Articles proposing stacks, cycles or loading phases are inventing structure that no evidence supports and that the label's own caution rules out.

The same discipline decides what a new article would have to be. It would have to answer a question this panel actually raises, from sources a reader can open, and it would have to be worth reading by somebody who has no intention of buying anything.

If a reformulation changes the panel, these articles change with it, and the review date at the foot of every page on this website moves. Three of the five are built directly on specific rows, so a new label would make them wrong rather than merely out of date. That is the kind of correction most worth sending to this desk, and the address for it is on the contact page.

Until then these five stand as written, with the dates on them, and with every identifier printed so that anybody who wants to check a claim can do it without asking permission. That is the only guarantee a journal attached to a retail desk can honestly offer, and it is worth more than a promise of impartiality nobody in this position could keep.